Product image of Neiromidin (Ipidacrine Hydrochloride) supplied by GNH India

Neiromidin

Active Ingredient:
Ipidacrine Hydrochloride
Origin:
EU

Neiromidin (Ipidacrine Hydrochloride)

Ipidacrine Hydrochloride, the active ingredient in Neiromidin, is an acetylcholinesterase inhibitor presented as an oral tablet for systemic administration. By inhibiting acetylcholinesterase, it increases acetylcholine levels, supporting neuromuscular transmission and cognitive function in relevant disorders.

GNH India supplies Neiromidin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with the product sourced from EU‑regulated manufacturers and meeting stringent quality standards. The company provides reliable logistics and regulatory support for cross‑border shipments and timely delivery, ensuring patient access.

Manufacturer / TM Owner

Olpha As

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Neiromidin (Ipidacrine Hydrochloride) acts as an acetylcholinesterase inhibitor and is used in neuromuscular and cognitive disorders.

  • Myasthenia gravis: improves muscle strength by enhancing neuromuscular transmission.
  • Dementia (including Alzheimer’s disease): may modestly improve cognitive symptoms through increased central acetylcholine.
  • Post‑stroke cognitive impairment: supports recovery of attention and memory functions.

How It Works

  • Neiromidin contains ipidacrine hydrochloride, which reversibly binds to the active site of acetylcholinesterase enzymes. This inhibition slows the hydrolysis of acetylcholine in synaptic clefts, leading to elevated concentrations of the neurotransmitter at both peripheral neuromuscular junctions and central cholinergic pathways. The resulting enhancement of cholinergic signaling improves muscle contraction efficiency and may augment cognitive processes dependent on acetylcholine.

Side Effects

Neiromidin may be associated with several adverse reactions, ranging from mild to serious.

Common Side Effects

  • Nausea: mild gastrointestinal upset.
  • Headache: transient cranial discomfort.
  • Dizziness: occasional light‑headedness.
  • Fatigue: general tiredness.

Serious or Rare Side Effects

  • Bradycardia: markedly reduced heart rate requiring medical attention.
  • Severe cholinergic crisis: muscle weakness, respiratory difficulty, and excessive salivation.
  • Allergic reactions: rash, itching, or anaphylaxis in rare cases.

Precautions & Warnings

When prescribing Neiromidin, clinicians should consider several precautionary measures to ensure safe use.

  • Assess neuromuscular status: evaluate for myasthenic symptoms before initiating therapy.
  • Monitor cardiac function: watch for bradycardia, especially in patients with pre‑existing conduction disorders.
  • Review concomitant cholinergic drugs: avoid additive cholinergic effects.
  • Caution in hepatic impairment: dose adjustment may be required due to hepatic metabolism.
  • Pregnancy and lactation: use only if potential benefit outweighs risk, as safety data are limited.
  • Store at ambient temperature: keep below 25 °C, in original packaging, protected from moisture.

Avoid Interactions

Neiromidin can interact with other medications that influence cholinergic activity or cardiac conduction.

Major Interactions (Avoid)

  • Anticholinergic agents (e.g., atropine, scopolamine): may counteract therapeutic effect.
  • Beta‑blockers and calcium channel blockers: increased risk of bradycardia.
  • Other acetylcholinesterase inhibitors (e.g., donepezil, rivastigmine): risk of cholinergic overload.

Moderate Interactions (Monitor Closely)

  • QT‑prolonging drugs (e.g., quinidine, macrolide antibiotics): may exacerbate cardiac conduction effects.
  • Diuretics: potential electrolyte disturbances affecting cardiac rhythm.
  • CNS depressants (e.g., benzodiazepines): may enhance dizziness or fatigue.

Frequently Asked Questions

Neiromidin contains ipidacrine hydrochloride and is prescribed primarily for myasthenia gravis, certain forms of dementia, and post‑stroke cognitive deficits. By enhancing cholinergic transmission, it helps improve muscle strength and may support cognitive function in these conditions.

Ipidacrine is a reversible acetylcholinesterase inhibitor. It binds to the enzyme’s active site, slowing the breakdown of acetylcholine. The resulting increase in acetylcholine concentration amplifies signaling at neuromuscular junctions and central cholinergic pathways, which can improve muscle contraction and cognitive processes.

The dosage of Neiromidin is individualized by the prescribing clinician based on the patient’s condition, age, renal and hepatic function, and response to therapy. Specific dosing regimens are not provided here and should be obtained from a qualified healthcare professional.

Safety data for ipidacrine in pregnancy and lactation are limited. The drug should be used only if the potential benefit justifies any possible risk to the fetus or infant, and the decision must be made by the treating physician.

To request Neiromidin, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Neiromidin (ipidacrine) is a reversible inhibitor similar to donepezil or rivastigmine but differs in its chemical structure and pharmacokinetic profile. It may have a shorter half‑life and distinct side‑effect patterns, making it a useful alternative when patients experience intolerance to other agents.

Neiromidin tablets should be stored at ambient temperature, preferably below 25 °C. Keep them in the original packaging, protect from moisture and direct sunlight, and keep out of reach of children.

Neiromidin is taken orally, usually with water. The tablet should be swallowed whole and not crushed or chewed unless otherwise instructed by a healthcare professional.

The most serious adverse events include bradycardia, severe cholinergic crisis (characterized by muscle weakness, respiratory difficulty, and excessive salivation), and rare allergic reactions such as anaphylaxis. Patients should seek immediate medical attention if any of these symptoms occur.

Neiromidin is contraindicated in patients with known hypersensitivity to ipidacrine or any excipients, those with severe cardiac conduction disorders, and individuals taking high‑dose anticholinergic medications that could negate its effect. Clinical judgment is required for patients with significant hepatic impairment.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Ipidacrine Hydrochloride

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT